Evidence map›Paper›PMID 32818402›Full record

ArticleEmerging infectious diseases2020

Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru.

William H Elson, Robert C Reiner, Crystyan Siles, Isabel Bazan, Stalin Vilcarromero, Amy R Riley-Powell, Ania B Kawiecki, Helvio Astete, Robert D Hontz, Chris M Barker and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

William H Elson
Robert C Reiner
Crystyan Siles
Isabel Bazan
Stalin Vilcarromero
Amy R Riley-Powell
Ania B Kawiecki
Helvio Astete
Robert D Hontz
Chris M Barker
Gonzalo M Vazquez-Prokopec
Amy C Morrison
Thomas W Scott
John P Elder
Alan L Rothman
Valerie A Paz-Soldan
University of California, Davis · USNaval Medical Research Unit Six · PEProvidence College · USUniversity of Rhode Island · USUniversity of Washington · USEmory University · USTulane University · USUniversity of Sussex · GB

Funding

Surveillance Core (B)P01AI098670 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MORRISON, AMY CELESTE · 2014 to 2018
$7.9M
NIAID NIH HHS P01 AI098670Wellcome TrustWellcome Trust 212712/Z/18/Z
6 · The paper itself

Abstract

Measuring heterogeneity of dengue illness is necessary to define suitable endpoints in dengue vaccine and therapeutic trials and will help clarify behavioral responses to illness. To quantify heterogeneity in dengue illness, including milder cases, we developed the Dengue Illness Perceptions Response (IPR) survey, which captured detailed symptom data, including intensity, duration, and character, and change in routine activities caused by illness. During 2016-2019, we collected IPR data daily during the acute phase of illness for 79 persons with a positive reverse transcription PCR result for dengue virus RNA. Most participants had mild ambulatory disease. However, we measured substantial heterogeneity in illness experience, symptom duration, and maximum reported intensity of individual symptoms. Symptom intensity was a more valuable predicter of major activity change during dengue illness than symptom presence or absence alone. These data suggest that the IPR measures clinically useful heterogeneity in dengue illness experience and its relation to altered human behavior.

Indexed as

DengueDengue VirusHumansPeruProspective StudiesSurveys and Questionnairescohort studiescommunity-based prospective studydenguedengue virusepidemiologyheterogeneityhumansIquitosPeruviruses

Identifiers

PMID32818402
PMCPMC7454099
OpenAlexW3044842790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.